A Randomized, Single Centre, Double Blind Three Treatment Three Period, Crossover Glucose Clamp Study to Test for Bioequivalence between Recombinant Human Insulins, Wockhardtâ??sWosulin Regular Insuln Human (E. Coli) with Wockhardtâ??s Wosulin Regular Insulin Human (Yeast) and Bioequivalence between Wockhardtâ??s Wosulin Regular Insulin Human (E.Coli) with Humulin® R, in Healthy Subjects

Trial Profile

A Randomized, Single Centre, Double Blind Three Treatment Three Period, Crossover Glucose Clamp Study to Test for Bioequivalence between Recombinant Human Insulins, Wockhardtâ??sWosulin Regular Insuln Human (E. Coli) with Wockhardtâ??s Wosulin Regular Insulin Human (Yeast) and Bioequivalence between Wockhardtâ??s Wosulin Regular Insulin Human (E.Coli) with Humulin® R, in Healthy Subjects

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Insulin (Primary)
  • Indications Diabetes mellitus
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors Wockhardt
  • Most Recent Events

    • 29 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top